荣昌马上就要拿下抑制_老虎社区_美港股上老虎

荣昌马上就要拿下抑制PD-1和VEGF的定价权了。 $三生制药(01530)$ $荣昌生物(09995)$ $康方生物(09926)$ 艾伯维和辉瑞也都在搞这个靶点。虽然康方做出来效果一般，但有这两个外企撑腰，再加上荣昌在A股和港股的表现，这定价权估计最后还是荣昌说了算。荣昌卤鹅加油涨停

创新药利好不断！还有进场机会吗？

创新药板块利好不断，药明康德公布2025年业绩，净利润149亿，同比+41%；荣昌生物与艾伯维签署授权许可协议，最高可获49.5亿美元里程碑付款；当地时间2026年1月12日，第44届摩根大通(JPM)医疗健康年会在旧金山正式启幕。据悉，截至目前，多家中国创新药企确认参会。【在当前行情下，创新药是你看好的板块吗？】

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":521313155080304,"tweetId":"521313155080304","gmtCreate":1768307180974,"gmtModify":1768307185758,"author":{"id":10000000000010490,"idStr":"10000000000010490","authorId":10000000000010490,"authorIdStr":"10000000000010490","name":"三藏大法师","avatar":"https://static.tigerbbs.com/0c5f20005843fcfdee4fc28ff79506cf","vip":8,"userType":8,"introduction":".\n","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":196,"starInvestorFlag":false},"themes":[{"themeId":"5295300d7a5d43469f7e004a8a52759a","categoryId":"d316d8bd4a714fab9ea15fd7157c45e7","name":"创新药利好不断！还有进场机会吗？","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":5295300d7a5d43469f7e004a8a52759a}&rnconfig={\"headerBarHidden\": true}","description":"创新药板块利好不断，药明康德公布2025年业绩，净利润149亿，同比+41%；荣昌生物与艾伯维签署授权许可协议，最高可获49.5亿美元里程碑付款；当地时间2026年1月12日，第44届摩根大通(JPM)医疗健康年会在旧金山正式启幕。据悉，截至目前，多家中国创新药企确认参会。【在当前行情下，创新药是你看好的板块吗？】","image":"https://static.tigerbbs.com/3b37f036cb04b5c9130f32429f11130a"}],"images":[],"coverImages":[],"html":"<html><head></head><body><p>荣昌马上就要拿下抑制PD-1和VEGF的定价权了。 <a data-mention-id=\"01530\" class=\"teditor-mention\" data-mention-name=\"三生制药\" href=\"https://laohu8.com/S/01530\">$三生制药(01530)$</a>  <a data-mention-id=\"09995\" class=\"teditor-mention\" data-mention-name=\"荣昌生物\" href=\"https://laohu8.com/S/09995\">$荣昌生物(09995)$</a>  <a data-mention-id=\"09926\" class=\"teditor-mention\" data-mention-name=\"康方生物\" href=\"https://laohu8.com/S/09926\">$康方生物(09926)$</a> 艾伯维和辉瑞也都在搞这个靶点。虽然康方做出来效果一般，但有这两个外企撑腰，再加上荣昌在A股和港股的表现，这定价权估计最后还是荣昌说了算。荣昌卤鹅加油涨停</p></body></html>","htmlText":"<html><head></head><body><p>荣昌马上就要拿下抑制PD-1和VEGF的定价权了。 <a data-mention-id=\"01530\" class=\"teditor-mention\" data-mention-name=\"三生制药\" href=\"https://laohu8.com/S/01530\">$三生制药(01530)$</a>  <a data-mention-id=\"09995\" class=\"teditor-mention\" data-mention-name=\"荣昌生物\" href=\"https://laohu8.com/S/09995\">$荣昌生物(09995)$</a>  <a data-mention-id=\"09926\" class=\"teditor-mention\" data-mention-name=\"康方生物\" href=\"https://laohu8.com/S/09926\">$康方生物(09926)$</a> 艾伯维和辉瑞也都在搞这个靶点。虽然康方做出来效果一般，但有这两个外企撑腰，再加上荣昌在A股和港股的表现，这定价权估计最后还是荣昌说了算。荣昌卤鹅加油涨停</p></body></html>","text":"荣昌马上就要拿下抑制PD-1和VEGF的定价权了。 $三生制药(01530)$ $荣昌生物(09995)$ $康方生物(09926)$ 艾伯维和辉瑞也都在搞这个靶点。虽然康方做出来效果一般，但有这两个外企撑腰，再加上荣昌在A股和港股的表现，这定价权估计最后还是荣昌说了算。荣昌卤鹅加油涨停","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/521313155080304","repostId":0,"isVote":1,"tweetType":1,"viewCount":1057,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["01530","09995","09926","688331"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":true,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":238,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/521313155080304"}